-
Mashup Score: 1Support Services | LUNGevity Foundation - 1 hour(s) ago
LUNGevity offers the largest online network of support and in-person survivorship programs for all people affected by lung cancer. Through our LifeLine Program, we offer one-on-one support by matching patients and caregivers to mentors who have similar experiences. We also provide supporters and advocates the opportunity to participate on our social media platforms to connect with each other and raise awareness about lung cancer, the importance of funding lung cancer research, and changing how people
Source: www.lungevity.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Case 2: A 48-Year-Old Man with Renal Cell Carcinoma - 2 hour(s) ago
Sumanta Kumar Pal, MD, FASCO, presents the case of a 48-year-old man with renal cell carcinoma, and Rana R. McKay, MD, discusses how she discusses risk of recurrence with patients.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Novel targets & agents in myeloma - 2 hour(s) ago
In this discussion, Faith Davies, MD, MRCP, MRCPath, FRCPath, NYU Langone, New York City, NY, Mala Shanmugam, MS, PhD, Emory School of Medicine, Atlanta, GA, and Sikander Ailawadhi, MD, Mayo Clinic, Jacksonville, FL, give an overview of a session held at this year’s meeting which focused on novel targets and agents in myeloma. The experts cover a variety of exciting therapeutic strategies, including combination approaches with CELMoDs, how to overcome venetoclax resistance, and Phase I trials evaluating novel platforms which may be used to deliver therapies to patients. This session was filmed at the 17th International Workshop on Multiple Myeloma (iwMyeloma) held in Miami, FL. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Shop Talk : Oncology Times - 2 hour(s) ago
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Science Behind Targeted Drug for Pediatric Brain Cancer Has Dana-Farber Roots | Dana-Farber Cancer Institute - 2 hour(s) ago
Scientific detective work helped transform a previously shelved drug into a medicine now approved for relapsed or progressive pediatric low-grade glioma.
Source: blog.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Mother's Day Reflections: Gratitude for a Lifetime of Love - 3 hour(s) ago
Moffitt patient loses her mother to cancer two years after her own diagnosis
Source: www.moffitt.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Mohty Shares Key Takeaway From the 50th Annual EMBT Meeting, Highlighting Treatment of GVHD - 3 hour(s) ago
Mohamad Mohty, MD, PhD, highlights key takeaways from the 50th Annual EMBT Meeting, focusing on ongoing efforts within the GVHD treatment arena.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1UGN-102 With/Without TURBT Produces Similar DOR and DFS in Newly Diagnosed and Recurrent NMIBC - 3 hour(s) ago
UGN-102 with/without TURBT displayed meaningful and similar DFS and DOR rates in newly diagnosed and recurrent low-grade intermediate-risk NMIBC.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Adjuvant versus salvage radiotherapy: debates will be reignited - 4 hour(s) ago
Dr. Parker and colleagues report in the current issue of Annals of Oncology the updated results of the RADICALS-RT randomized trial evaluating the superiority of adjuvant radiotherapy (ART) versus early salvage radiotherapy (eSRT).1 Based on the similar biochemical control results reported after a median follow-up of 4.9 years, eSRT was deemed by many as the standard of care for predominately clinically intermediate-risk men post-radical prostatectomy (RP). 2
Source: www.annalsofoncology.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0ASTCT Talks: Beyond Remission: Navigating the Late Effects of Pediatric CAR T-Cell Therapy - 4 hour(s) ago
In this episode “ASTCT Talks,” hosts Rebecca Epperly, MD, and Aimee Talleur, MD, from St. Jude Children’s Research Hospital, dive into the pioneering realm of CAR T-cell therapy and…
Source: www.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
LUNGevity offers the largest online network of support & in-person survivorship programs for all people affected by #lungcancer. Patients/caregivers can receive peer-to-peer support & information from their message boards. Learn More: https://t.co/0QPwMOSfXi #LCAM23 #LCSM https://t.co/S9VMxFrMwE